Emerging Biotech
Duke-NUS Launches LIVE Ventures: S$20M to Commercialize Academic Research
Duke-NUS Medical School launched LIVE Ventures, a S$20 million incubation programme designed to catalyse the commercialisation of innovative acad...
July 22, 2024 | News
ADM Korea to Submit IND for Niclosamide-Based Combination Therapy for Prostate Cancer
IND for clinical study for combination therapy with hormone therapy in prostate cancer patients to be submitted in August, 2024. Niclosamide-based metab...
July 12, 2024 | News
Zhejiang Doer Biologics Completes Enrollment for Phase 1b/2a Trial of DR10624 in Obese Subjects with Hypertriglyceridemia
Zhejiang Doer Biologics, a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announc...
July 08, 2024 | News
Genoks and Velsera Partner to Transform Cancer Diagnostics and Treatment in Turkey
Genoks, a leading Turkish genomics healthcare company, and Velsera, a global healthcare technology company offering a universal software platform to connec...
July 01, 2024 | News
IASO Biotechnology Secures NMPA Approval for IND Application of RD118 CAR-T Therapy Targeting GPRC5D for Relapsed/Refractory Multiple Myeloma
IASO Biotechnology , a biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing innovative cell therapies and antibody pr...
July 01, 2024 | News
Hyundai Bioscience Develops Innovative Niclosamide-Based Multi-Treatment Drug for Mosquito-Borne Viral Infections
Developed a 'Niclosamide-based multi-treatment drug' that can simultaneously treat mosquito-borne viral infections such as four serotypes of dengue virus...
June 26, 2024 | News
Singleron Biotechnologies Partners with Human Cell Atlas to Boost Global Adoption of Single Cell Sequencing
Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate the adoption of single cell sequencing globally. Singl...
June 19, 2024 | News
Enveda Biosciences Secures $55 Million in Latest Financing Round
Enveda Biosciences a biotechnology company using AI to translate nature into new medicines, announced today a new financing round of $55 million to add to ...
June 17, 2024 | News
Thailand BOI Approves Eight Major Projects Worth 56.95 Billion Baht
The Thailand Board of Investment (BOI) today approved investment promotion applications for eight large-scale projects totaling 56.95 billion baht (USD 1.5...
June 17, 2024 | News
Novotech Launches Early Phase Unit for Biotechs in Australian and New Zealand Clinical Environment
Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and n...
June 14, 2024 | News
Asahi Kasei Launches Innovative Membrane System for WFI Production, Reducing CO2 Emissions and Costs
Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI (water for injection), a type of sterile water that is ...
June 14, 2024 | News
NSG BioLabs Partners with Eppendorf to Propel Biotech Startups in Singapore
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the start...
June 13, 2024 | News
Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals
Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...
June 11, 2024 | News
EnGeneIC and Singapore Institute of Advanced Medicine Partner to Transform Cancer Treatment in Asia
EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announce...
June 07, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
